These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23255118)

  • 1. Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.
    Lesovaya E; Yemelyanov A; Kirsanov K; Popa A; Belitsky G; Yakubovskaya M; Gordon LI; Rosen ST; Budunova I
    Cell Cycle; 2013 Jan; 12(1):133-44. PubMed ID: 23255118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562.
    Lesovaya EA; Yemelyanov AY; Kirsanov KI; Yakubovskaya MG; Budunova IV
    Biochemistry (Mosc); 2011 Nov; 76(11):1242-52. PubMed ID: 22117551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.
    Yemelyanov A; Bhalla P; Yang X; Ugolkov A; Iwadate K; Karseladze A; Budunova I
    Cell Cycle; 2012 Jan; 11(2):395-406. PubMed ID: 22223138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1.
    De Bosscher K; Beck IM; Dejager L; Bougarne N; Gaigneaux A; Chateauvieux S; Ratman D; Bracke M; Tavernier J; Vanden Berghe W; Libert C; Diederich M; Haegeman G
    Cell Mol Life Sci; 2014 Jan; 71(1):143-63. PubMed ID: 23784308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Anti-Cancer Activity of the Novel Selective Glucocorticoid Receptor Agonists of the Phenylethanolamine Series.
    Zhidkova EM; Tilova LR; Fetisov TI; Kirsanov KI; Kulikov EP; Enikeev AD; Budunova IV; Badun GA; Chernysheva MG; Shirinian VZ; Yakubovskaya MG; Lesovaya EA
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity.
    Lesovaya E; Yemelyanov A; Swart AC; Swart P; Haegeman G; Budunova I
    Oncotarget; 2015 Oct; 6(31):30730-44. PubMed ID: 26436695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
    Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a.
    Robertson S; Allie-Reid F; Vanden Berghe W; Visser K; Binder A; Africander D; Vismer M; De Bosscher K; Hapgood J; Haegeman G; Louw A
    J Biol Chem; 2010 Mar; 285(11):8061-75. PubMed ID: 20037160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
    Zheng Y; Ishiguro H; Ide H; Inoue S; Kashiwagi E; Kawahara T; Jalalizadeh M; Reis LO; Miyamoto H
    Mol Endocrinol; 2015 Oct; 29(10):1486-97. PubMed ID: 26322830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
    Clarisse D; Van Wesemael K; Tavernier J; Offner F; Beck IM; De Bosscher K
    PLoS One; 2018; 13(5):e0197000. PubMed ID: 29738549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia.
    Koyama D; Kikuchi J; Hiraoka N; Wada T; Kurosawa H; Chiba S; Furukawa Y
    Leukemia; 2014 Jun; 28(6):1216-26. PubMed ID: 24301524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
    Scheinman RI; Gualberto A; Jewell CM; Cidlowski JA; Baldwin AS
    Mol Cell Biol; 1995 Feb; 15(2):943-53. PubMed ID: 7823959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin.
    Klopot A; Baida G; Bhalla P; Haegeman G; Budunova I
    J Cancer Prev; 2015 Dec; 20(4):250-9. PubMed ID: 26734587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proteasome: a novel target for anticancer therapy.
    Montagut C; Rovira A; Albanell J
    Clin Transl Oncol; 2006 May; 8(5):313-7. PubMed ID: 16760005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
    Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
    Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome inhibitors in the treatment of B-cell malignancies.
    Schenkein D
    Clin Lymphoma; 2002 Jun; 3(1):49-55. PubMed ID: 12141956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fully dissociated compound of plant origin for inflammatory gene repression.
    De Bosscher K; Vanden Berghe W; Beck IM; Van Molle W; Hennuyer N; Hapgood J; Libert C; Staels B; Louw A; Haegeman G
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15827-32. PubMed ID: 16243974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful T-cell acute lymphoblastic leukemia treatment with proteasome inhibitor bortezomib based on evaluation of nuclear factor-κB activity.
    Hu X; Xu J; Sun A; Shen Y; He G; Guo F
    Leuk Lymphoma; 2011 Dec; 52(12):2393-5. PubMed ID: 21745166
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts.
    Gossye V; Elewaut D; Bougarne N; Bracke D; Van Calenbergh S; Haegeman G; De Bosscher K
    Arthritis Rheum; 2009 Nov; 60(11):3241-50. PubMed ID: 19877072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The possible separation of 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation and hyperplasia by compound A.
    Kowalczyk P; Kowalczyk MC; Junco JJ; Tolstykh O; Kinjo T; Truong H; Walaszek Z; Hanausek M; Slaga TJ
    Mol Carcinog; 2013 Jun; 52(6):488-96. PubMed ID: 22351517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.